Prosecution Insights
Last updated: April 19, 2026
Application No. 16/950,093

MEDICAL CONDITIONS IN BODY CAVITIES

Non-Final OA §103§112
Filed
Nov 17, 2020
Examiner
EKRAMI, YASAMIN
Art Unit
3794
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Coologics Inc.
OA Round
3 (Non-Final)
42%
Grant Probability
Moderate
3-4
OA Rounds
4y 9m
To Grant
90%
With Interview

Examiner Intelligence

Grants 42% of resolved cases
42%
Career Allow Rate
123 granted / 294 resolved
-28.2% vs TC avg
Strong +48% interview lift
Without
With
+47.7%
Interview Lift
resolved cases with interview
Typical timeline
4y 9m
Avg Prosecution
15 currently pending
Career history
309
Total Applications
across all art units

Statute-Specific Performance

§101
1.7%
-38.3% vs TC avg
§103
50.2%
+10.2% vs TC avg
§102
18.0%
-22.0% vs TC avg
§112
26.9%
-13.1% vs TC avg
Black line = Tech Center average estimate • Based on career data from 294 resolved cases

Office Action

§103 §112
DETAILED ACTION Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on 02/21/2025 has been entered. Notice of Pre-AIA or AIA Status The present application is being examined under the pre-AIA first to invent provisions. Information Disclosure Statement The information disclosure statement (IDS) submitted on 02/21/2025 has been considered by the examiner. Claim Status Applicant’s amendments in the response filed on 02/21/2025 has been considered by the Examiner. Currently, claims 1-7 and 10 are pending, claims 1 and 5 have been amended, claim 10 is newly added. In addition, claims 8-9 are canceled and the Examiner withdraws the previously filed 112(b) rejection. Information Disclosure Statement The information disclosure statement (IDS) submitted on 02/21/2025 has been considered by the examiner. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 2 and 7 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 2 recites “wherein the filler is at least one of a gas, a liquid and a solid.” However, claim 1 requires the filler to comprise a frozen material. Claim 7 recites “a removable plug”. It is unclear if the limitation is one of or in addition to “a removable plug” recited in claim 1. Claim Rejections - 35 USC § 103 The following is a quotation of pre-AIA 35 U.S.C. 103(a) which forms the basis for all obviousness rejections set forth in this Office action: (a) A patent may not be obtained though the invention is not identically disclosed or described as set forth in section 102, if the differences between the subject matter sought to be patented and the prior art are such that the subject matter as a whole would have been obvious at the time the invention was made to a person having ordinary skill in the art to which said subject matter pertains. Patentability shall not be negatived by the manner in which the invention was made. Claims 1-3 and 7 is/are rejected under pre-AIA 35 U.S.C. 103(a) as being unpatentable over Sarson (1,729,296) in view of Singleton (Patent No. 4,240,436). Regarding claim 1, Sarson teaches a device to treat an overgrowth of yeast in a vagina comprising a shell, a first end, a second end and a chamber within the shell (Col. 1 line 1 For the treatment of the inner female genitals Sarson teaches a device comprising a bladder b that is inserted into the vagina, cock f is opening and water is forced from bladder a into bladder b), wherein the chamber is sealed with a removable plug (screw stopper d); wherein the second end is rounded (bladder b), and the first end comprises a removal means (intermediate element c, cock f, mouthpiece e, bladder a); wherein the chamber is configured to house a filler (water; Col. 1 line 6); wherein the shell comprises a malleable unfreezable material (bladder b is made of extensible rubber or rubber skin so that it can be inflated; Col. 1 lines 47-58); wherein the filler comprises a material that is refreezable (cold water is used to treat inflammations Col 2 lines 68-70); wherein, when the filler is frozen and the shell is inserted into a body cavity, the shell cools the vagina to a temperature that prevents a replication of yeast and provides relief to symptoms associated within an overgrowth of yeast (the device of Sarson is inserted into the vagina for a period of time to provide cooling to relieve inflammation Col. 2 lines 68-70). Sarson is silent about specifically teaching the refreezable material is frozen, Singleton teaches a device within the same field of invention (perineal ice pack comprises raised surface portions being adapted for partial insertion into both said vaginal and rectal openings; Claim 1 wherein the device contains a cold temperature storage means such as water or a chemical slurry which is a mixture of 10% isopropyl alcohol and water which creates a semi-pliable slurry at a temperature of 20 degrees Fahrenheit; Col. 3 lines 35 -40). Therefore, it would have been obvious to one of ordinary skill before the effective filing date of the claimed invention to have modified the filler such that it includes a slurry since it has a freezing point between zero and 32 degrees Fahrenheit and provides for the appropriate therapy. One of ordinary skill in the art can replace water with slurry since it has been held to be within the general skill of a worker in the art to select a known material on the basis of its suitability for the intended use as a matter of obvious design choice. In re Leshin, 125 USPQ 416. While Sarson is silent about specifically teaching wherein the device is reusable after each use it would have been obvious to one of ordinary skill in the art at the time the invention was made to reuse the device since it has been held that a recitation with respect to the manner in which a claimed apparatus is intendent to be employed does not differentiate the claimed apparatus from a prior art apparatus satisfying the claimed structural limitations. Ex parte Masham, 2 USPQ2D 1647 (1987). Regarding claim 2, Sarson in view of Singleton teaches the limitations of claim 1 and wherein the filler is at least one of a gas, a liquid and a solid (chemical slurry which is a mixture of 10% isopropyl alcohol and water). Regarding claim 3, Sarson teaches the limitations of claim 1 and wherein the filler is at least one of saline, distilled water, and a gel (chemical slurry which is a mixture of 10% isopropyl alcohol and water). Regarding claim 7, Sarson teaches the limitations of claim 1 further comprising a removable plug adapted to seal an opening of the chamber (screw cap d). Claims 4-5 is/are rejected under pre-AIA 35 U.S.C. 103(a) as being unpatentable over Sarson (1,729,296) in view of Singleton (Patent No. 4,240,436) and in further view of Ponder (Patent No. 5,539,934). Regarding claims 4, Sarson in view of Singleton teaches the limitations of claim 1. While the chamber of Sarson includes a first compartment (bladder b), it does not teach a second compartment. However, Ponder teaches a device within the same field of invention (cooling apparatus), wherein the device includes a first and second compartment (annular chamber of the bladder further comprising water, and a waterproof membrane 13 containing at least one capsule comprising a salt capable of producing an endothermic reaction with the water and a water soluble coating encapsulating the salt). Therefore, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to have modified the device in Sarson to include an additional compartment for the purposes of including salt tablets such that when the compartment breaks and mixes with the water in the first compartment, it extends a cooling effect (Claim 1; Col. 2 lines 37-39). Regarding claim 5, Sarson in view of Singleton and Ponder teaches the limitations of claim 4. Ponder provides wherein the first compartment is filled with a first compound (annular chamber includes water ) and the second compartment is filled with a second compound (waterproof membrane 13 includes capsules 14), wherein the first compartment and second compartment are separated by breakable walls, wherein the walls are broken, the compounds mix to create a cooling gel (membrane 13 is capable of being ruptured or broken when deformed by an external force ; Col. 2 line 39…Claim 1 the annular chamber of the bladder further comprising water, at least one capsule and a waterproof membrane, said at least one capsule comprising a salt capable of producing an endothermic reaction with the water and a water soluble coating encapsulating the salt and thereby extending a cooling effect). Claim 6 is/are rejected under pre-AIA 35 U.S.C. 103(a) as being unpatentable over Sarson (1,729,296) in view of Singleton (Patent No. 4,240,436) and in further view of Jacobson (Pub. No. 2004/0176827). Regarding claim 6, Sarson in view of Singleton teaches the limitations of claim 1. Sarson does not teach wherein the removal means comprises a string attached to the shell, wherein pulling on the string removes the device from the vagina. However, Jacobson teaches a device within the same field of invention (thermal therapy applicator) wherein the device comprises a string Fig. 5. Therefore, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to include a string on the proximal end of the device in Sarson since Jacobson provides the string may be used instead of the handle to allow removal of the device from the body cavity [0026]. Claim 10 is/are rejected under pre-AIA 35 U.S.C. 103(a) as being unpatentable over Sarson (1,729,296) in view of Singleton (Patent No. 4,240,436), Jacobson (Pub. No. 2004/0176827), and in further view of Fleshman (2010/0174209). Regarding claim 10, Sarson teaches a device to treat an overgrowth of yeast in a vagina comprising: a shell comprising a first end, a second end and a chamber within the shell (Col. 1 line 1 For the treatment of the inner female genitals Sarson teaches a device comprising a bladder b that is inserted into the vagina, cock f is opening and water is forced from bladder a into bladder b), wherein the chamber is sealed with a removable plug (screw stopper d) and wherein the shell comprises a malleable unfreezable material (bladder b is made of extensible rubber or rubber skin so that it can be inflated; Col. 1 lines 47-58); a filler housed in the chamber (water; Col. 1 line 6), wherein the filler comprises a material that is refreezable (cold water is used to treat inflammations Col 2 lines 68-70); wherein, when the filler is frozen and the shell is inserted into a body cavity, the shell cools the vagina to a temperature that prevents a replication of yeast and provides relief to symptoms associated within an overgrowth of yeast (the device of Sarson is inserted into the vagina for a period of time to provide cooling to relieve inflammation Col. 2 lines 68-70). Sarson is silent about specifically teaching the refreezable material is frozen, Singleton teaches a device within the same field of invention (perineal ice pack comprises raised surface portions being adapted for partial insertion into both said vaginal and rectal openings; Claim 1 wherein the device contains a cold temperature storage means such as water or a chemical slurry which is a mixture of 10% isopropyl alcohol and water which creates a semi-pliable slurry at a temperature of 20 degrees Fahrenheit; Col. 3 lines 35 -40). Therefore, it would have been obvious to one of ordinary skill before the effective filing date of the claimed invention to have modified the filler such that it includes a slurry since it has a freezing point between zero and 32 degrees Fahrenheit and provides for the appropriate therapy. One of ordinary skill in the art can replace water with slurry since it has been held to be within the general skill of a worker in the art to select a known material on the basis of its suitability for the intended use as a matter of obvious design choice. In re Leshin, 125 USPQ 416. While Sarson is silent about specifically teaching wherein the device is reusable after each use it would have been obvious to one of ordinary skill in the art at the time the invention was made to reuse the device since it has been held that a recitation with respect to the manner in which a claimed apparatus is intendent to be employed does not differentiate the claimed apparatus from a prior art apparatus satisfying the claimed structural limitations. Ex parte Masham, 2 USPQ2D 1647 (1987). Sarson does not teach a removal loop formed in the first end. However, Jacobson teaches a device within the same field of invention (thermal therapy applicator) wherein the device comprises a removal element (string Fig. 5). Therefore, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to include a string on the proximal end of the device in Sarson since Jacobson provides the string may be used instead of the handle to allow removal of the device from the body cavity [0026]. The combination does not provide wherein the removal element (string) is a loop. However, Fleshman teaches a medical device that has a removal element in the shape of a loop (grasping end 16). Therefore, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to have modified the shape of the removal element (string) such that it has a shape of a loop since Fleshman teaches the loop is an easy to grasp handle design [0035]. Response to Remarks Applicant’s arguments in the response filed on 02/21/2025 has been considered by the Examiner. Applicant’s remarks regarding the Harris reference were persuasive; therefore, the Examiner withdraws the rejection under 35 U.S.C 102(a)(1). Applicant’s amendments necessitate a new grounds of rejection over Sarson (1,729,296) in view of Singleton (Patent No. 4,240,436) for claim 1. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to YASAMIN EKRAMI whose telephone number is (571)272-9803. The examiner can normally be reached 9:00-5:00. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Joanne M. Hoffman can be reached at (303) 297-4276. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /Y.E/ Examiner, Art Unit 3794 /KAITLYN E SMITH/ Primary Examiner, Art Unit 3794
Read full office action

Prosecution Timeline

Nov 17, 2020
Application Filed
Jul 12, 2023
Non-Final Rejection — §103, §112
Oct 19, 2023
Response Filed
Aug 17, 2024
Final Rejection — §103, §112
Feb 21, 2025
Request for Continued Examination
Feb 24, 2025
Response after Non-Final Action
Oct 15, 2025
Non-Final Rejection — §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12551367
TEMPERATURE CONTROL AGENT, AND HEATING COMPOSITION, PACKAGING MATERIAL, AND WARMING MATERIAL EACH COMPRISING SAME
2y 5m to grant Granted Feb 17, 2026
Patent 12427055
PATIENT HEAT EXCHANGE SYSTEM WITH TWO AND ONLY TWO FLUID LOOPS
2y 5m to grant Granted Sep 30, 2025
Patent 12419781
Method and Apparatus for Controlling the Inner Temperature of a Patient
2y 5m to grant Granted Sep 23, 2025
Patent 12082917
SYSTEMS, DEVICES, AND METHODS FOR ASSESSING EFFICACY OF RENAL NEUROMODULATION THERAPY
2y 5m to grant Granted Sep 10, 2024
Patent 12053296
DEVICE CONFIGURED TO BE SUPPORTED ON A HUMAN BODY, TO MEASURE A BIOLOGICAL PARAMETER OF THE HUMAN BODY, AND TO CONTROL A CHARACTERISTIC OF THE HUMAN BODY
2y 5m to grant Granted Aug 06, 2024
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

3-4
Expected OA Rounds
42%
Grant Probability
90%
With Interview (+47.7%)
4y 9m
Median Time to Grant
High
PTA Risk
Based on 294 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month